126 related articles for article (PubMed ID: 33128543)
1. iASPP protects the heart from ischemia injury by inhibiting p53 expression and cardiomyocyte apoptosis.
Yagudin T; Zhao Y; Gao H; Zhang Y; Yang Y; Zhang X; Ma W; Daba TM; Ishmetov V; Kang K; Yang B; Pan Z
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):102-111. PubMed ID: 33128543
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
3. Oncogene iASPP enhances self-renewal of hematopoietic stem cells and facilitates their resistance to chemotherapy and irradiation.
Jia Y; Peng L; Rao Q; Xing H; Huai L; Yu P; Chen Y; Wang C; Wang M; Mi Y; Wang J
FASEB J; 2014 Jul; 28(7):2816-27. PubMed ID: 24668753
[TBL] [Abstract][Full Text] [Related]
4. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke.
Liu X; Li F; Zhao S; Luo Y; Kang J; Zhao H; Yan F; Li S; Ji X
Stroke; 2013 Jul; 44(7):1973-80. PubMed ID: 23696548
[TBL] [Abstract][Full Text] [Related]
6. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
8. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.
Wilson AM; Chiodo VA; Boye SL; Brecha NC; Hauswirth WW; Di Polo A
PLoS One; 2014; 9(4):e94175. PubMed ID: 24714389
[TBL] [Abstract][Full Text] [Related]
11. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of ASPP2, iASPP and p53 in cervical cancinoma and the significance].
Ouyang M; Hu Y; Zeng F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 40(3):256-60. PubMed ID: 25832528
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
Notari M; Hu Y; Koch S; Lu M; Ratnayaka I; Zhong S; Baer C; Pagotto A; Goldin R; Salter V; Candi E; Melino G; Lu X
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16645-50. PubMed ID: 21930934
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults.
Budhram-Mahadeo V; Fujita R; Bitsi S; Sicard P; Heads R
Cell Death Dis; 2014 Oct; 5(10):e1503. PubMed ID: 25356872
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions.
Meng WD; Chu RX; Wang BZ; Wang LP; Ma LL; Wang LX
Pathol Biol (Paris); 2013 Oct; 61(5):199-202. PubMed ID: 23528480
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of iASPP ameliorates hypoxia/reoxygenation-induced apoptosis and oxidative stress in cardiomyocytes by upregulating Nrf2 signaling.
Bai B; Zeng G; Chen R; Ai Y; Qiang H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22686. PubMed ID: 33332723
[TBL] [Abstract][Full Text] [Related]
17. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma.
Chan KK; Wong ES; Wong IT; Cheung CL; Wong OG; Ngan HY; Cheung AN
BMC Cancer; 2019 Oct; 19(1):953. PubMed ID: 31615473
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents.
Shen L; Chen C; Wei X; Li X; Luo G; Zhang J; Bin J; Huang X; Cao S; Li G; Liao Y
Clin Sci (Lond); 2015 May; 128(10):665-78. PubMed ID: 25511237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
